The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years - PubMed (original) (raw)
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years
E E Powell et al. Hepatology. 1990 Jan.
Abstract
Forty-two patients with nonalcoholic steatohepatitis were followed for a median of 4.5 yr (range = 1.5 to 21.5 yr). Except for two patients with lipodystrophy, all were obese; 35 of 42 were women, 26 of 32 were hyperlipidemic and 15 were hyperglycemic. Upper abdominal pain was the most common reason for presentation. Initial liver biopsy specimens showed the presence of macrovesicular fatty infiltration, lobular (acinar) inflammation, apoptosis, Mallory bodies (in four cases) and fibrosis (in 18 cases). Cirrhosis was present at initial diagnosis in one subject and in another two subjects liver biopsy showed marked fibrosis with disturbed architecture. Serial liver biopsy specimens revealed minimal or no apparent progression of the disorder in most of the patients, in keeping with their benign clinical course. However, one patient showed progression from fibrosis to cirrhosis during the 5-yr observation period, and in the patients with extensive fibrosis the liver disease evolved from one of active inflammation to one of inactive cirrhosis without fat or inflammation. The patient with cirrhosis later died of hepatocellular carcinoma. The severity or type of hepatic change did not correlate with the degree of obesity, hyperlipidemia or hyperglycemia. However, in individual patients, poorly controlled diabetes and rapid weight loss preceded the onset of steatohepatitis. We conclude that nonalcoholic steatohepatitis is a cause of hepatic inflammation histologically resembling that of alcohol-induced liver disease but usually slowly progressive and of low-grade severity. However, the disorder may ultimately result in cirrhosis. Nonalcoholic steatohepatitis should be distinguished from alcoholic steatohepatitis and recognized as a further cause of "cryptogenic cirrhosis."
Comment in
- The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease.
Caldwell SH, Crespo DM. Caldwell SH, et al. J Hepatol. 2004 Apr;40(4):578-84. doi: 10.1016/j.jhep.2004.02.013. J Hepatol. 2004. PMID: 15030972 No abstract available.
Similar articles
- Two cases from the spectrum of nonalcoholic steatohepatitis.
Abdelmalek M, Ludwig J, Lindor KD. Abdelmalek M, et al. J Clin Gastroenterol. 1995 Mar;20(2):127-30. doi: 10.1097/00004836-199503000-00011. J Clin Gastroenterol. 1995. PMID: 7769192 - Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.
Pinto HC, Baptista A, Camilo ME, Valente A, Saragoça A, de Moura MC. Pinto HC, et al. Dig Dis Sci. 1996 Jan;41(1):172-9. doi: 10.1007/BF02208601. Dig Dis Sci. 1996. PMID: 8565753 - Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Angulo P, Keach JC, Batts KP, Lindor KD. Angulo P, et al. Hepatology. 1999 Dec;30(6):1356-62. doi: 10.1002/hep.510300604. Hepatology. 1999. PMID: 10573511 - Obesity and hepatocellular carcinoma.
Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Caldwell SH, et al. Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. doi: 10.1053/j.gastro.2004.09.021. Gastroenterology. 2004. PMID: 15508109 Review. - Nonalcoholic fatty liver disease: a systematic review.
Rinella ME. Rinella ME. JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. JAMA. 2015. PMID: 26057287 Review.
Cited by
- Long-Term Administration of Fibroblast Growth Factor 21 Prevents Chemically-Induced Hepatocarcinogenesis in Mice.
Xu P, Zhang Y, Wang W, Yuan Q, Liu Z, Rasoul LM, Wu Q, Liu M, Ye X, Li D, Ren G. Xu P, et al. Dig Dis Sci. 2015 Oct;60(10):3032-43. doi: 10.1007/s10620-015-3711-z. Epub 2015 May 24. Dig Dis Sci. 2015. PMID: 26003555 - Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients.
Bozzetto L, Prinster A, Annuzzi G, Costagliola L, Mangione A, Vitelli A, Mazzarella R, Longobardo M, Mancini M, Vigorito C, Riccardi G, Rivellese AA. Bozzetto L, et al. Diabetes Care. 2012 Jul;35(7):1429-35. doi: 10.2337/dc12-0033. Diabetes Care. 2012. PMID: 22723581 Free PMC article. Clinical Trial. - A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm.
Runyon BA. Runyon BA. Int J Hepatol. 2011;2011:801983. doi: 10.4061/2011/801983. Epub 2011 Oct 26. Int J Hepatol. 2011. PMID: 22121492 Free PMC article. - Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
Yang HR, Kim HR, Kim MJ, Ko JS, Seo JK. Yang HR, et al. World J Gastroenterol. 2012 Apr 7;18(13):1525-30. doi: 10.3748/wjg.v18.i13.1525. World J Gastroenterol. 2012. PMID: 22509085 Free PMC article. - Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R. Permutt Z, et al. Aliment Pharmacol Ther. 2012 Jul;36(1):22-9. doi: 10.1111/j.1365-2036.2012.05121.x. Epub 2012 May 3. Aliment Pharmacol Ther. 2012. PMID: 22554256 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources